Selective serotonin reuptake inhibitors affect structure, function and metabolism of skeletal muscle: A systematic review

被引:10
|
作者
Visco, Diego Bulcao [1 ]
Manhaes-de-Castro, Raul [2 ]
Chaves, Wenicios Ferreira [1 ]
Lacerda, Diego Cabral [1 ]
Pereira, Sabrina da Conceicao [3 ]
Ferraz-Pereira, Kelli Nogueira [4 ]
Toscano, Ana Elisa [5 ]
机构
[1] Univ Fed Pernambuco, Postgrad Program Nutr, Recife, PE, Brazil
[2] Univ Fed Pernambuco, Dept Nutr, Recife, PE, Brazil
[3] Univ Fed Pernambuco, Postgrad Program Phys Therapy, Recife, PE, Brazil
[4] Univ Fed Pernambuco, CAV, Dept Phys Educ & Sports Sci, Vitoria De Santo Antao, PE, Brazil
[5] Univ Fed Pernambuco, CAV, Dept Nursing, Rua Alto Reservatorio S-N, BR-55608680 Vitoria De Santo Antao, PE, Brazil
关键词
Serotonin uptake inhibitors; Serotonin; Skeletal muscle; Systematic review; CONGENITAL MYASTHENIC SYNDROME; CUTANEOUS SILENT PERIOD; FLUOXETINE TREATMENT; MYOTONIC-DYSTROPHY; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; NEONATAL TREATMENT; DIABETES-MELLITUS; RAT; ANTIDEPRESSANTS;
D O I
10.1016/j.phrs.2018.09.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Selective Serotonin Reuptake Inhibitors (SSRIs) may have side effects, such as stiffness, tremors and altered tonic activity, as well as an increased risk of developing insulin resistance and diabetes mellitus. However, little is known about the structural, functional and metabolic changes of skeletal muscle after administration of SSRIs. The aim of this systematic review was to explore and discuss the effects of SSRIs on skeletal muscle properties described in human and rodent studies. A systematic search of PUBMED, SCOPUS, and WEB OF SCIENCE was performed. The inclusion criteria were intervention studies in humans and rodents that analysed the effects of SSRIs on skeletal muscle properties. The research found a total of six human studies, including two randomized controlled trials, one non-randomized controlled trial, one uncontrolled before-after study and two case reports, and six preclinical studies in rodents. Overall, the studies in humans and rodents showed altered electrical activity in skeletal muscle function, assessed through electromyography (EMG) and needle EMG in response to chronic treatment or local injection with SSRIs. In addition, rodent studies reported that SSRIs may exert effects on muscle weight, the number of myocytes and the cross-sectional area of skeletal muscle fibre. The results showed effects in energy metabolism associated with chronic SSRI use, reporting altered levels of glycogen synthase activity, acetyl-CoA carboxylase phosphorylation, citrate synthase activity, and protein kinase B Ser phosphorylation. Moreover, changes in insulin signalling and glucose uptake were documented. In this context, we concluded based on human and rodent studies that SSRIs affect electrical muscle activity, structural properties and energy metabolism in skeletal muscle tissue. However, these changes varied according to pre-existing metabolic and functional conditions in the rodents and humans.
引用
收藏
页码:194 / 204
页数:11
相关论文
共 50 条
  • [31] The genetics of selective serotonin reuptake inhibitors
    Kroeze, Yvet
    Zhou, Huiqing
    Homberg, Judith R.
    PHARMACOLOGY & THERAPEUTICS, 2012, 136 (03) : 375 - 400
  • [32] A Systematic Review of the Acute Effects of Hemodialysis on Skeletal Muscle Perfusion, Metabolism, and Function
    Almushayt, Shatha J.
    Hussain, Samia
    Wilkinson, Daniel J.
    Selby, Nicholas M.
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (03): : 307 - 317
  • [33] Selective serotonin reuptake inhibitors (SSRI) affect murine bone lineage cells
    Durham, Emily
    Zhang, Yuhua
    LaRue, Amanda
    Bradshaw, Amy
    Cray, James
    LIFE SCIENCES, 2020, 255
  • [34] Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors as adjuncts for postoperative pain management: systematic review and meta-analysis of randomised controlled trials
    Wang, Li
    Tobe, Joshua
    Au, Emily
    Tran, Cody
    Jomy, Jane
    Oparin, Yvgeniy
    Couban, Rachel J.
    Paul, James
    BRITISH JOURNAL OF ANAESTHESIA, 2022, 128 (01) : 118 - 134
  • [35] SAFETY AND ANTIDEPRESSANT EFFICACY OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS
    KASPER, S
    HOFLICH, G
    SCHOLL, HP
    MOLLER, HJ
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1994, 9 (01) : 1 - 12
  • [36] The effects of selective serotonin reuptake inhibitors on platelet function in whole blood and platelet concentrates
    Reikvam, Anne-Grete
    Hustad, Steinar
    Reikvam, Hakon
    Apelseth, Torunn Oveland
    Nepstad, Ina
    Hervig, Tor Audun
    PLATELETS, 2012, 23 (04) : 299 - 308
  • [37] The Association Between Selective Serotonin Reuptake Inhibitors and Glycemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Tharmaraja, Thahesh
    Stahl, Daniel
    Hopkins, Christopher W. P.
    Persaud, Shanta J.
    Jones, Peter M.
    Ismail, Khalida
    Moulton, Calum D.
    PSYCHOSOMATIC MEDICINE, 2019, 81 (07): : 570 - 583
  • [38] Selective serotonin reuptake inhibitors (SSRIs) for post-partum depression (PPD): A systematic review of randomized clinical trials
    De Crescenzo, Franco
    Perelli, Federica
    Armando, Marco
    Vicari, Stefano
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 152 : 39 - 44
  • [39] Long-term harms from previous use of selective serotonin reuptake inhibitors: A systematic review
    Danborg, P. B.
    Valdersdorf, M.
    Gotzsche, P. C.
    INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2019, 30 (02) : 59 - 71
  • [40] The impact of selective serotonin reuptake inhibitors on the risk of intracranial haemorrhage: A systematic review and meta-analysis
    Jensen, Melanie P.
    Ziff, Oliver J.
    Banerjee, Gargi
    Ambler, Gareth
    Werring, David J.
    EUROPEAN STROKE JOURNAL, 2019, 4 (02) : 144 - 152